# Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

> **NCT06057051** · NA · RECRUITING · sponsor: **Glaukos Corporation** · enrollment: 245 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** iStent Infinite

## Key facts

- **NCT ID:** NCT06057051
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-08
- **Final completion:** 2027-08
- **Target enrollment:** 245 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057051, "Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06057051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*